Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Carisbamate for Partial-Onset Seizures
2008-007687-41Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Focal Onset Epilepsy and epilepsy comparing Carisbamate adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Responder rate. Started Dec 2008; status: completed.
02
Drugs
carisbamate
03
Conditions
Focal Onset Epilepsyepilepsy
Beyond the preview
Go deeper on 2008-007687-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007687-41.